To find evidence of alterations in leukocyte homeostasis, we collected CD45+ PBMCs from 12 HDs (n = 12) and a varying number of COVID-19 patients with different clinical conditions (mild, n = 4; severe, n = 5; and critical, n = 3; Supplementary Fig. 1a). This evidence concerns the gene PTPRC and COVID-19.